ACIP: COVID-19 Vaccine Should Be Offered to HCPs, LTC Residents First
The recommendation was made based on the number of confirmed COVID-19 cases among these 2 groups, as well as ethical and scientific considerations.
COVID19
Pandemic-Related Delays in Cancer Screenings and Treatment Threaten Progress in Cancer Mortality Rates
If the current COVID-19 trends persist, the NCI estimates that the pandemic’s impact could threaten the trend of annually decreasing cancer mortality seen in the US since 1990.
As Rollout Nears, Small Practices and Rural Clinics Anticipate Challenges Storing and Administering COVID-19 Vaccines
Storing and administering a COVID-19 vaccine presents logistical challenges for many small practices and rural clinics.
FDA Authorizes COVID-19 Test That Provides Rapid Results at Home
This is the first time the Agency has authorized a COVID-19 diagnostic test that provides rapid results at home.
Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective
The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.
Investigational Cancer Immunotherapy May Be Repurposed for COVID-19 Treatment
CPI-006, a B-cell activating antibody which is under development as an anticancer therapy, showed early efficacy as a potential treatment for COVID-19.
Survey Reveals Factors Contributing to COVID-19 Vaccine Acceptance
To estimate the association between attribute level and probability of choosing and receiving a vaccine, the study authors calculated the average marginal component effects sizes as well as marginal means.
Case Report Details COVID-19 Reinfection in Immunocompromised Patient
A case report detailed reinfection with SARS-CoV-2 in an immunocompromised patient with Waldenström macroglobulinemia.
COVID-19–Free Surgical Pathways Benefit Patients Undergoing Elective Cancer Surgery
Elective cancer surgery within COVID-19–free surgical pathways results in lower pulmonary complication, SARS-CoV-2 infection, and mortality rates.
Early Study Termination Muddles Benefit of Hydrocortisone in COVID-19
Patients with severe COVID-19 may benefit from a fixed-dose or shock-dependent dosing of hydrocortisone, but early study termination hindered definitive conclusions.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...